Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
The Fas-FasL system: from apoptosis regulator to therapeutic target in autoimmunity, cancer, and transplantation
Immunologic Research
December 2026
Gadelkarim M.
Serum CD95 (Fas/APO-1) as a biomarker of liver injury and fibrosis among Iraqi patients with chronic hepatitis C virus infection
Microbes and Infectious Diseases
August 2026
Al-Jobory H.S.
Open Access
Insights into the Biochemical and Immune Mechanisms in Drug-Induced Liver Injury Pathogenesis
Chemical Research in Toxicology
16 March 2026
Saville E.
Open Access
Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells
Exploration of Targeted Anti Tumor Therapy
2023
Zhang Q.
Open Access
Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects
International Journal of Molecular Sciences
October 2022
Zuccalà P.
Open Access
Intestinal IL-17R Signaling Constrains IL-18-Driven Liver Inflammation by the Regulation of Microbiome-Derived Products
Cell Reports
19 November 2019
Castillo-dela Cruz P.
Open Access
Generation of a rat model of acute liver failure by combining 70% partial hepatectomy and acetaminophen
Journal of Visualized Experiments
November 2019
Sahay P.
Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease
Cell Death and Disease
1 February 2019
Cubero F.J.
Open Access
Characteristics of levels of serum markers of apoptosis fas-systems in HIV-mono-infected persons, patients with HIV/HCV-co-infection and chronic viral hepatitis C
HIV Infection and Immunosuppressive Disorders
2019
Bazykina E.A.
Open Access
Hepatitis B virus surface antigen enhances the sensitivity of hepatocytes to fas-mediated apoptosis via suppression of AKT phosphorylation
Journal of Immunology
15 October 2018
Jing Z.T.
All Open Access, Green
Evaluation of alternative serum biomarkers to monitor the progression of chronic HBV and HCV infection
Infection Genetics and Evolution
March 2018
Tsiomita S.
Synergistic interaction of the cannabinoid and death receptor systems – a potential target for future cancer therapies?
FEBS Letters
October 2017
Keresztes A.
Open Access
Genetic polymorphisms of Fas/FasL promoter associated with hepatitis C cirrhosis and HCC
Asian Pacific Journal of Cancer Prevention
1 October 2017
Abed S.
Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients
Journal of Interferon and Cytokine Research
August 2017
El-Mesery M.
IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans
Jci Insight
8 December 2016
Alzaid F.
Open Access
Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: Simple noninvasive score
European Journal of Gastroenterology and Hepatology
1 August 2016
Toson E.S.A.
Exploring multiple quantitative trait loci models of hepatic fibrosis in a mouse intercross
Mammalian Genome
1 February 2016
Hall R.A.
Antitumor and apoptosis induction effects of hederagenin on hepatocarcinoma (H22) tumor-bearing mice
Latin American Journal of Pharmacy
2016
Bai X.
Expression of cluster of differentiation-95 and relevant signaling molecules in liver cancer
Molecular Medicine Reports
1 May 2015
Wang X.
Open Access
HuR suppresses fas expression and correlates with patient outcome in liver cancer
Molecular Cancer Research
1 May 2015
Zhu H.
Open Access
Prediction and analysis of hepatocellular carcinoma related genes using gene ontology and KEGG
Current Bioinformatics
1 March 2015
Jiang M.